Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Imperial College Innovation Fund (ICIF) is a venture capital investment vehicle dedicated to supporting early-stage high-growth companies spinning out of Imperial College London. Managed by Parkwalk Advisors in collaboration with the university, the fund provides critical seed and Series A capital to commercialize world-class research across life sciences, healthcare, and deep technology. By leveraging the extensive academic and entrepreneurial ecosystem of Imperial College, the fund identifies and nurtures ventures with the potential to address global challenges in medicine and engineering. Its portfolio includes a diverse range of startups focused on innovative therapeutic modalities, medical devices, and digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imperial Venture Fund.